Articles by Jon S. Kauffman, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jon S. Kauffman, PhD

Jon S. Kauffman, PhD

Manager

Jon S. Kauffman, PhD, is the manager of method development and validation at Lancaster Laboratories, Inc.

Articles
Identification and Risk-Assessment of Extractables and Leachables
February 1, 2006

Extractable and leachable issues should be resolved early in the drug manufacturing process. Open communication is imperative for a successful study.

Trends in Impurity Analyis: Determination of Extractables, Leachables, Residual Solvents, and Unknowns by Mass Spectrometry
August 1, 2003

Advances in mass spectrometry have made it a valuable tool for use in the quality-control laboratory.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here